Viruses are parasites and can only replicate by hijacking human cell metabolism. ViroCarb’s drug platform targets a cell function (RNA processing) crucial to viral, but not human cell propagation. This MOA translates into a broad-spectrum host cell resistance to multiple known and potentially new emerging viruses and endows a low propensity for drug resistance, which limits standard current virus targeted therapies.
Copyright © 2024 ViroCarb Inc. - All Rights Reserved.